Serum aldo –keto reductase family 1 member B10 predicts advanced liver fibrosis and fatal complications of nonalcoholic steatohepatitis

ConclusionAKR1B10 is a useful serum biomarker for advanced liver fibrosis in NASH and, combined with serum WFA(+)-M2BP, can predict HCC development, gastroesophageal varix formation, and poor prognosis.

http://link.springer.com/10.1007/s00535-019-01551-3

Source: Journal of Gastroenterology - February 1, 2019 Category: Gastroenterology Source Type: research